Telogen Effluvium in a 36-Year-Old Female After Birth Control Change

Hair shedding can be alarming, especially when it begins abruptly. Telogen effluvium (TE) is one of the most common causes of sudden, diffuse hair shedding in women—and it is often triggered by hormonal changes, stress, or internal shifts within the body. At Reena Jogi MD in Katy and Houston, Texas, we frequently evaluate patients with similar symptoms and help them navigate recovery through education, targeted treatments, and close follow-up.

This case highlights a 36-year-old woman experiencing diffuse hair thinning after a recent birth control change, demonstrating the importance of proper diagnosis and a tailored treatment plan.

Patient Background

A 36-year-old female presented as a new patient with a chief complaint of diffuse hair loss that began 4 months ago. She described the hair shedding as:

  • Moderate in severity

  • Gradual in onset

  • Diffuse across the scalp

She also noted a history of noticeable hair thinning approximately 1 month after switching birth control pills, suggesting a hormonal trigger. She denied meaningful scalp pain, burning, or irritation.

Family History

The patient reported hair loss in her mother, which can contribute to baseline hair density patterns or underlying genetic hair thinning.

Physical Examination

A thorough examination included:

  • Scalp and hair inspection

  • Head and face evaluation

  • Dermatoscopic exam for follicular assessment

Exam Findings

  • Patient appeared well-developed and well-nourished

  • Alert and oriented ×3

  • No acute distress

  • Positive hair pull test—consistent with active telogen shedding

  • Diffuse shedding noted on the posterior mid-parietal, right central frontal, and left central frontal scalp

No scarring or inflammatory signs were present.

Diagnosis: Telogen Effluvium (TE)

Based on her clinical history, timing of symptoms, and exam findings, the patient was diagnosed with telogen effluvium, a temporary shedding cycle in which hair prematurely enters the telogen (resting) phase.

In this case, the most likely trigger was her recent birth control change, a common hormonal cause of TE.

To further confirm the diagnosis, a punch biopsy was offered.

Treatment Discussion

A full counseling session was provided, covering the nature of telogen effluvium and its typical recovery timeline.

Key Education Points

  • TE is self-limited, usually resolving within several months

  • Common triggers include illness, stress, nutritional deficiencies, thyroid abnormalities, and medications

  • Regrowth can be gradual and may lag several months behind the initial trigger

  • Underlying organic causes should be identified and addressed

Treatment Options Reviewed

The following therapies were discussed in detail, including side effects:

After discussing all options, the patient elected to begin spironolactone.

Final Treatment Plan

1. Spironolactone 50 mg

Prescription:
50 mg tablets

  • Take 1 tablet daily for 1 week

  • Then increase to 1 tablet in the morning + 1 tablet at bedtime

  • If well tolerated, may take both tablets at once

Side Effects Reviewed:

  • Breast tenderness

  • Menstrual irregularities

  • Dizziness

  • Fatigue

  • Elevated potassium levels

  • Not safe in pregnancy

2. Begin Topical Minoxidil 5% Solution

Recommended to support regrowth and reduce prolonged shedding.

3. Optional Future Treatments

  • PRP therapy

  • AlmaTED

  • Laser therapy

4. Follow-Up

Return in 3 months to reassess shedding, scalp health, and response to spironolactone.

Conclusion

This case illustrates a classic presentation of telogen effluvium triggered by a hormonal change. With appropriate counseling, targeted therapy, and close monitoring, most patients experience significant recovery as hair follicles naturally re-enter the growth phase. At Reena Jogi MD, we focus on patient-specific evaluation to determine triggers and curate individualized hair restoration plans.

Women in Katy and Houston, Texas seeking evaluation for sudden or diffuse hair thinning can benefit from early diagnosis and supportive care—often preventing unnecessary worry and promoting faster recovery.

Previous
Previous

Androgenetic Alopecia in a 40-Year-Old Woman — PRP Recommended After Limited Response to Topical Therapy

Next
Next

42-Year-Old Female Beginning Isotretinoin (Accutane) for Persistent Acne